Abstract
Creutzfeldt-Jakob disease or spastic pseudosclerosis was a term applied by Jakob to a set of patients first described by Creutzfeldt (1920).
Keywords
- Multiple Sclerosis
- Bovine Spongiform Encephalopathy
- Transmissible Spongiform Encephalopathy
- Fatal Familial Insomnia
- Spongiform Change
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Anderson RM, Donnelly CA, Ferguson NM, Woolhouse MEJ, Watt CJ, Udy HJ, Mawhinney S, Dunstan SP, Southwood TRE, Wilesmith JW, Ryan JBM, Hoinville LJ, Hillerton JE, Austin AR, Wells GAH. Transmission dynamics and epidemiology of BSE in British cattle. Nature. 1996;382:779–88.
Aoki T, Gibbs CJ, Sotelo J, Gajdusek CD. Heterogeneic autoantibody against neurofilament protein in sera of animals with experimental kuru and Creutzfeldt-Jakob disease and natural scrapie infection. Infect Immun. 1982;38:316–24.
Cousens S, Smith PG, Ward H, Everington D, Knight RS, Zeidler M, Stewart G, Smith-Bathgate EA, Macleod MA, Mackenzie J, Wills RG. Geographical distribution of variant-Creutzfeldt-Jakob disease in Great Britain 1994–2000. Lancet. 2001;357:1002–7.
Gajdusek DC, Gibbs CJ, Alpers M. Transmission and passage of experimental kuru to chimpanzees. Science. 1967;155:212–4.
Galvez S, Farcas A, Monari M. Cerebrospinal fluid and serum immunoglobulins and C3 in Creutzfeldt-Jakob disease. Neurology. 1979;29:1610–2.
Giese A, Brown DR, Groschup MH, Feldmann C, Haist I, Kretschmar HA. Role of microglia in neuronal cell death in prion disease. Brain Pathol. 1998;8:449–57.
Jakob Uber eigenartige Erkrankungen des Zentralnervensystems mit Bemerkenswerten anatomischen Befunden. Spastische Pseudosklerose Encephalopathie mit disseminierte Degenerationsherden. Z ges Neurol Psychiater. 1920;64:146.
Irani DN. The classic and variant forms of Creutzfeldt-Jakob disease. Semin Clin Neuropsychiatry. 2003;8:71–9.
Klein MA, Frigg R, Flechsig E, Raeber AJ, Kalinke U, Bluethmann U, Bootz E, Suter M, Zinkernagel RM, Aguzzi A. A crucial role for B cells in neuroinvasive scrapie. Nature. 1987;390:687–90.
Kohira I, Tsuji T, Ishizu H, Takao Y, Wake A, Abe K, Kuroda S. Elevation of neuron-specific enolase in serum and cerebrospinal fluid of early stage Creutzfeldt-Jaskob disease. Acta Neurol Scand. 2000;102:385–7.
Kovacs GG, Gasque P, Strobel T, Lindeck-Pozza E, Strohschneider M, Ironside JW, Budka H, Guentchen M. Complement activation in human prion disease. Neurobiol Dis. 2004;15:21–8.
Lewicki H, Tishon A, Homann D, Mazarquil H, Laval F, Asensio VC, Campbell IL, DeArmond S, Coon B, Teng C, Gairin JE, Oldstone MBA. T cells infiltrate the brain of murine and human transmissible spongiform encephalopathies. J Virol. 2003;77:3799–808.
Mabbott NA, Bruce ME. The immunobiology of TSE diseases. J Gen Virol. 2001;82:2307–18.
Manuelidis L, Yu ZX, Barquero N, Banquero N, Mullins B. Cells infected with scrapie and Creutzfeldt-Jakob disease agents produce intracellular 25 nm virus like particles. Proc Natl Acad Sci USA. 2007;104:1965–70.
Peden AH, Head MW, Ritchie DL, Bell JE, Ironside JW. Pre-clinical v-CJD after blood transfusion in a PRNP codon heterozygous patient. Lancet. 2004;364:527–9.
Pugliatti M, Sotgiu S, Rosati G. The worldwide prevalence of multiple sclerosis. Clin Neurol Neurosurg. 2002;104:182–91.
Scholz R, Lorenzen S. Phantom BSE-Gefahr. Innsbruck: Berenkamp; 2005.
Sotelo J, Gibbs CJ, Gajdusek DC. Autoantibodies against axonal neurofilaments in patients with kuru and Creutzfeldt-Jakob disease. Science. 1980;210:190–3.
Toh DH, Gibbs CJ, Gajdusek DC, Tutdill DD, Dahl D. The 200 and 150-kDa neurofilaments protein react with IgG autoantibodies from chimpanzees with kuru or Creutzfeldt-Jakob disease; a 62 kDa neurofilament associated protein reacts with sera from sheep with natural scrapie. Proc Natl Acad Sci U S A. 1985;82:3894–6.
Van Everbroeck B, Dewulf E, Pals P, Lübke U, Martin JJ, Cras P. The role of cytokines, astrocytes, microglia and apoptosis in Creutzfeldt-Jakob disease. Neurobiol Aging. 2002;23:59–64.
Venters GA. New variant Creutzfeldt-Jakob dfisease: the epidemic that never was. Bit Med J. 2001;323:858–61.
Volkel D, Zimmermann K, Zerr I, Lindner T, Bodemer M, Poser S, Schwarz HS. C-reactive protein and Il-6: new marker proteins for the diagnosis of CJD in plasma? Transfusion. 2001;41:1509–14.
Ward HJT, Everington D, Cousens SN, Smith-Bathgate B, Leitch M, Cooper S, et al. Risk factors for variant Creutzfeldt-Jakob disease: a case-control study. Ann Neurol. 2006;59:111–20.
Wientjens DP, Davanipour Z, Hofman A, Kondo K, Mattlews WB, Will RG, Van Duijn CM. Risk factors for Creutzfeldt-Jakob disease: a re-analysis of case-control studies. Neurology. 1996;46:1287–91.
Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K, Alperovitch A, Poser S, Pocchiari M, Hofman A, Smith PG. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet. 1996;347:921–5.
Will RG, Alperovitch A, Poser S, Pocchiari M, Hoiffman A, Mitrova E, et al. Descriptiver epidemiology of Creutzfeldt-Jakob disease in six European countries. Ann Neurol. 1998;43:763–7
Zerr I, Poser S. Clinical diagnosis and differential diagnosis of CJD and variant-CJD. APMIS. 2002;110:88–98.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Ebringer, A. (2015). Creutzfeldt-Jakob Disease and its Variants. In: Multiple Sclerosis, Mad Cow Disease and Acinetobacter. Springer, Cham. https://doi.org/10.1007/978-3-319-02735-7_16
Download citation
DOI: https://doi.org/10.1007/978-3-319-02735-7_16
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-02734-0
Online ISBN: 978-3-319-02735-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)